Assessment of a publicly available microarray dataset [53], showed that increases in ORAI3 were also evident in ERα-positive MCF-7 breast cancer cells, HT29 colon cancer cells and Du145 prostate cancer cells proportionate to increased exposure to hypoxia (Figure 2F). Here, ORAI3 is linked to breast cancer.